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Abstract
Tissue fibrosis is a major cause of mortality that results from the deposition of matrix proteins by 
an activated mesenchyme. Macrophages accumulate in fibrosis, but the role of specific subgroups 
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in supporting fibrogenesis has not been investigated in vivo. Here we used single-cell RNA 
sequencing (scRNA-seq) to characterize the heterogeneity of macrophages in bleomycin-induced 
lung fibrosis in mice. A novel computational framework for the annotation of scRNA-seq by 
reference to bulk transcriptomes (SingleR) enabled the subclustering of macrophages and revealed 
a disease-associated subgroup with a transitional gene expression profile intermediate between 
monocyte-derived and alveolar macrophages. These CX3CR1+SiglecF+ transitional macrophages 
localized to the fibrotic niche and had a profibrotic effect in vivo. Human orthologues of genes 
expressed by the transitional macrophages were upregulated in samples from patients with 
idiopathic pulmonary fibrosis. Thus, we have identified a pathological subgroup of transitional 
macrophages that are required for the fibrotic response to injury.
Fibrosing diseases are a major cause of mortality. Whether toxin-related, genetic, malignant, 
infectious, autoimmune or idiopathic, they can affect any organ1. Lung fibrosis is a 
particularly vexing clinical problem because of the lack of effective therapies and a poor 
understanding of its etiology. The most prevalent form, idiopathic pulmonary fibrosis, has a 
median survival of only 3 years, and approved treatments are limited2. With respect to the 
pathogenesis of fibrosis in multiple organs, attention has focused on fibroblast activation, 
given the central role of fibroblasts in the deposition of matrix proteins such as collagen3–6. 
However, the mechanisms of fibroblast activation and proliferation are not fully understood.
The healthy adult lung contains two types of resident macrophages: a self-renewing 
population of embryonically-derived macrophages known as alveolar macrophages and a 
separate population of interstitial macrophages present near the larger airways and in the 
lung interstitium7,8. In injury models of fibrosis, monocyte-derived cells are recruited to 
tissue sites and have a profibrotic effect9–11. However, the diversity of these cells and the 
mechanisms by which they mediate the profibrotic effect are incompletely understood, in 
part because the study of specific transcriptomic subsets has been limited by bulk 
sequencing approaches. In particular, the kinetically evolving heterogeneity inherent to 
disease cannot be parsed with the limited range of flow cytometric markers used to study 
populations in bulk. Because scRNA-seq can resolve diversity within cellular populations, 
we reasoned that it should enhance understanding of macrophage heterogeneity and specify 
subsets for functional analysis in fibrosis.
A current limitation in single cell analysis is that there are no prevalent methods for 
identification of cell types other than manual annotation, which suffers from subjectivity. 
Moreover, referencing conventional markers is challenged by incomplete mRNA detection. 
We developed a computational tool for unbiased annotation as well as clustering of scRNA-
seq, called SingleR (single cell recognition). SingleR assigns cellular identity for single cell 
transcriptomes by comparison to reference datasets of pure cell types sequenced by 
microarray or RNA-seq. Here, we used SingleR to identify macrophages from a mixed 
sample of lung cells at baseline and after bleomycin-induced lung injury in mice. In 
addition, we applied a novel hierarchical clustering approach based on SingleR correlations 
to subcluster macrophages in fibrosis, which enabled the identification of cells with 
transitional gene expression between monocyte-derived and alveolar macrophages. We used 
Aran et al. Page 2
Nat Immunol. Author manuscript; available in PMC 2019 July 14.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
markers identified by the subclustering analysis to investigate the functional properties of 
these transitional macrophages.
Our studies revealed that monocyte-derived, disease-associated macrophages transitioning to 
alveolar identity localized to the fibrotic niche and exerted a profibrotic effect. Specific 
ablation of these macrophages prevented lung fibrosis. Mechanistically, the scar-associated 
macrophages were the predominant source of the mitogen Pdgf-aa, which was necessary for 
proliferation of fibroblasts. These studies uncover a role for macrophages in the paracrine 
regulation of fibroblasts and provide a new perspective on myeloid-mesenchymal crosstalk 
in response to injury.
Results
Reference datasets enhance annotation of scRNA-seq
In order to improve annotation of cell types in scRNA-seq, we developed a computational 
method called SingleR, which correlated single cell transcriptomes with reference 
transcriptomic datasets and improved its inferences iteratively (Fig. 1a, Supplementary 
Information 1). The SingleR pipeline is based on correlating reference bulk RNA-seq 
datasets of pure cell types with single-cell gene expression. First, we validated SingleR 
using the Immunological Genome Project (ImmGen) database12 to annotate mouse scRNA-
seq and Encode13 and Blueprint Epigenomics14 transcriptomes to annotate human data. In 
the first step of the SingleR pipeline, a Spearman coefficient was calculated for single-cell 
gene expression with each of the samples in the reference dataset, using only the variable 
genes in the reference dataset. Using only variable genes among the cell types increased the 
ability to distinguish closely related cell types. This process was performed iteratively using 
only the top cell types from the previous step and the variable genes among them until only 
one cell type remained (for details see Methods, Supplementary Information 1 and the 
SingleR Github repository at https://github.com/dviraran/SingleR ).
To validate SingleR in mouse, we analyzed a published study of scRNA-seq of mouse bone 
marrow-derived dendritic cells (BMDC) and fibroblasts15. When applied to the ImmGen 
database12 as a reference library, SingleR identified 33 of the 48 cells thought in the study to 
be BMDCs as macrophages (Fig. 1b and Supplementary Information 2). Of note, cells in the 
study15 were grown in culture in the presence of the growth factor GM-CSF and then 
suspended for flow cytometric sorting based on CD11c expression, a protocol16,17 that has 
been shown not to result in a pure population of DCs but also results in a proportion of cells 
bearing macrophage markers18,19. As such, SingleR could make the distinction between 
macrophages and dendritic cells in an unbiased fashion based on the granularity and breadth 
of the transcriptomic comparison. In a separate validation, we applied SingleR using the 
Blueprint and Encode databases as reference comparators for a dataset generated by scRNA-
seq analysis of human peripheral blood mononuclear cells20. In comparison to marker-based 
and reference-based approaches20–22, which are limited in their ability to distinguish cell 
states, SingleR differentiated cellular subtypes such as memory and naïve B and T cells (Fig. 
1c and Supplementary Fig. 1). SingleR performed similarly when applied to >50 publicly 
available scRNA-seq datasets (Supplementary Information 2 and http://comphealth.ucsf.edu/
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SingleR/). These analyses show that reference-based comparison enhances cell type 
annotation of scRNA-seq.
SingleR identifies a transitional macrophage in fibrosis
We next applied SingleR to enhance annotation of a lung scRNA-seq dataset obtained from 
whole lungs of adult, male mice (10–12 weeks age) dissociated into single cell suspension 
and flow-sorted on live cells, using 6 steady-state mice and 3 mice 14 days after a single 
tracheal instillation of bleomycin, the fibrotic phase of the injury model (Fig. 2a, 
Supplementary Table 1 and Supplementary Fig. 2). Using the ImmGen database as the 
reference compendium of datasets for SingleR, we annotated the lung cells and 
superimposed these cellular identities on the clustering analysis of bleomycin and steady-
state cells, pooled together (Fig. 2b and Supplementary Fig. 3). The number of lung 
macrophages was higher in the bleomycin-treated condition than at steady state (Fig. 2a,b). 
Because macrophages and dendritic cells have similar transcriptomic profiles23–25, we 
repeated SingleR analysis using published RNA-seq datasets of mouse lung macrophages 
and dendritic cells26,27 to isolate the macrophages in the pooled bleomycin-injured and 
steady-state samples (Fig. 2c and Supplementary Fig. 4). SingleR identified two subtypes of 
macrophages: alveolar and interstitial macrophages (Fig. 2c). The annotation scores for 
alveolar and interstitial macrophages were strongest at the poles of the macrophage cluster, 
suggesting a continuum of gene expression between alveolar and interstitial macrophage 
(Fig. 2d). To quantify this continuum, we performed a similarity analysis28 by comparison 
of each cell to mouse RNA-seq datasets of alveolar and interstitial macrophages27. This 
analysis indicated a gradient of cellular identity in the macrophage cluster between alveolar 
and interstitial macrophage (Fig. 2d).
We next used SingleR annotation scores for each single cell compared with each sample in 
the reference dataset in order to hierarchically cluster the macrophages. That is, the full 
range of SingleR correlation scores for each cell with reference to ImmGen were used for 
unsupervised hierarchical clustering of the macrophages from the lung scRNA-seq dataset. 
This analysis identified three distinct subclusters (C1, C2 and C3), all three detected at 
varying levels in both steady-state and bleomycin-treated mice (Fig. 3a): cluster C1 was 
equally present in steady-state lung and bleomycin injury and corresponded to the cells that 
were annotated as alveolar macrophages by the lung-specific datasets (Fig. 2c); on the other 
hand, Clusters C2 and C3 were enriched in cells isolated from mice with bleomycin-induced 
fibrosis and expressed Cx3cr1, Ccr2, Mafb and MHCII genes, consistent with monocytic 
origin (Fig. 3b and Supplementary Table 2). Notably, 45% of cluster C2 cells (but only 7.3% 
of cluster C1 cells and 4.7% of cluster C3 cells) expressed at least 33% of cluster C1 genes 
and at least 33% of cluster C3 genes (Fig. 3c), suggesting that cluster C2 was intermediate in 
gene expression between C1 and C3. Consistent with this finding, comparison to 2 separate 
published datasets of lung macrophages27,29, enabling differential expression analysis 
between alveolar and interstitial macrophage genes, indicated that C1 had higher expression 
of alveolar macrophage genes than cluster C2, which in turn had higher alveolar macrophage 
genes than cluster C3 (Supplementary Fig. 5).
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In order to determine the directionality of the transitional state of C2 cells across time in the 
model, we performed bulk RNA-seq of SiglecF+CD11c+MHCIIlo and SiglecF+CD11c
+MHCIIhi cells, paralleling clusters C1 and C2, respectively. These cells were sorted from 
lungs of bleomycin-injured, 10–12-week-old, wild-type male mice. SiglecF+CD11c
+MHCIIhi macrophages had higher expression of genes identified by scRNA-seq in cells 
from clusters C2 and C3 compared to SiglecF+CD11c+MHCIIlo cells at 2 weeks after injury 
(Fig. 3d and Supplementary Fig. 6a). However, the expression of these genes in SiglecF
+CD11c+MHCIIhi cells at 4 weeks after injury was reduced to levels more similar to those 
detected in SiglecF+CD11c+ alveolar macrophages at steady-state (Fig. 3d). These data 
suggest that between the 2- and 4-week time points, SiglecF+CD11c+MHCIIhi cells, which 
correspond to cluster C2 identified by SingleR, transition toward a steady-state alveolar 
macrophage profile (corresponding to cluster C1).
Cluster C2 and C3 markers are found in alternate lung fibrosis models
In order to test the relevance of the identified gene expression pattern to other models of 
fibrosis, we used a mouse model of lung fibrosis induced by epithelial telomere dysfunction. 
In this model, SPC-CreERT2 mice are crossed with a Trf1fl/fl allele for tamoxifen-inducible 
deletion of Trf1, a shelterin complex protein that protects telomeres. Trf1 deletion after 
tamoxifen induction leads to age-dependent telomere shortening and is associated with 
cellular senescence and progressive fibrosis through the lifespan30. Whole lung lysates from 
SPC-CreERT2 / Trf1fl/fl mice harvested at 3 and 9 months after initiation of tamoxifen 
treatment and Trf1fl/fl control mice harvested at 9 months after tamoxifen were submitted for 
gene expression profiling by microarray. We detected a progressive increase in the 
expression of genes characteristic of clusters C2 and C3 in the lung lysates from tamoxifen-
treated SPC-CreERT2 / Trf1fl/fl mice compared to control, with peak expression at 9 months 
(Fig. 4a), coincident with peak fibrosis in this model. Although these data represent whole 
lung rather than isolated macrophages, together with the known increase in macrophages 
during the fibrotic period in this model30, the results are consistent with a common genetic 
signature and a generalizable pattern of macrophage response during fibrogenesis.
We then asked if the gene expression profiles identified in mouse were relevant for human 
lung fibrosis. To address this question, we performed single-sample gene set enrichment 
analysis (ssGSEA)31 to quantify the expression of human orthologues of genes of interest in 
a published microarray dataset of 167 lung samples from patients with lung fibrosis and 50 
healthy controls32. This analysis showed a significant decrease in the expression of genes 
associated with alveolar macrophages (cluster C1) and a significant increase in the 
expression of MHC II genes (cluster C2 and C3) in the human fibrosis samples compared to 
the healthy controls (Fig. 4b). Moreover, immunofluorescence of lung tissue indicated the 
expression of MAFB, a marker detected specifically in clusters C2 and C3, in CD68+ 
macrophages from patients with idiopathic lung fibrosis compared to healthy controls (Fig. 
4c). Taken together, these studies support the relevance of the C2 and C3 markers identified 
in the bleomycin model to multiple contexts of fibrosis, mouse and human.
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Cluster C2 macrophages localize to the fibrotic niche
Next, we tried to identify the anatomic niche of macrophage clusters C1, C2 and C3. 
Because Cx3cr1 was expressed in clusters C2 and C3 in the bleomycin-treated mice, we 
used mice expressing the tamoxifen-inducible allele Cx3cr1-CreERT233, which were 
crossed with Rosa26-loxp-STOP-loxp-TdTomato reporter mice to mark Cx3cr1-expressing 
cells with the fluorophore TdTomato. Tamoxifen was given every other day starting 1 day 
before bleomycin treatment until lung analysis on days 7 or 14, while control mice received 
the same tamoxifen schedule through day 14 without bleomycin to determine the baseline 
levels of TdTomato+ cells. At baseline, TdTomato+ cells represented 6% of the live lung 
cells by flow cytometry, likely representing the interstitial macrophages present in steady-
state lung (Fig. 5a and Supplementary Fig. 6b). In bleomycin-treated mice we observed an 
increase in the percentage of TdTomato+ cells among total lung live cells by flow cytometry 
at both day 7 (23%) and day 14 (38%) compared to baseline (Fig. 5a). Of note, the 
expression of the alveolar macrophage marker SiglecF on TdTomato+ cells increased (as 
assessed by mean fluorescence intensity) across the time series (Fig. 5a), indicating the 
acquisition of an alveolar macrophage marker by monocyte-derived macrophages across 
time.
We next performed lung immunofluorescence analysis of Cx3cr1-CreERT2 / Rosa26-loxp-
STOP-loxp-TdTomato mice at day 14 after bleomycin injury to determine the spatial 
organization of the macrophages in the fibrotic lung. TdTomato+SiglecF+ macrophages were 
detected in direct contact with clusters of fibroblasts as defined by areas delimited by 
multiple adjacent Pdgfrb+ cells (Fig. 5b). On the other hand, TdTomato-SiglecF+ alveolar 
macrophages (cluster C1) were detectable throughout the lung except in regions where 
Pdgfrb+ fibroblasts accumulated at sites of injury (Fig. 5b). The fact that TdTomato+ cells 
within the scar were also SiglecF+ suggests that the macrophages localizing to fibrotic zones 
were in a transitional state representative of cluster C2. Human CX3CR1 mRNA was also 
more highly expressed in lung microarray samples from 167 patients with lung fibrosis than 
in samples from 50 healthy controls (Fig. 5c)32, underscoring the relevance of the C2 cluster 
for human disease. Taken together, these results show that macrophage cluster C2 localizes 
to the fibrotic niche.
CX3CR1-expressing macrophages drive lung fibrosis
Because of the proximity of transitional macrophages to fibroblasts at fibrotic sites, we 
investigated whether the CX3CR1+ macrophages provided trophic or mitogenic support to 
fibroblasts. Macrophage-derived Pdgf has been shown to support fibroblast growth in co-
culture34. In the lung scRNA-seq dataset, Pdgfa was uniquely expressed in the fibrosis-
associated clusters C2 and C3 (Fig. 6a). Furthermore, Pdgfa mRNA was more highly 
expressed by bulk RNA-seq in SiglecF+CD11c+MHCIIhi (cluster C2) macrophages than 
SiglecF+CD11c+MHCIIlo macrophages (cluster C1) at two weeks (Fig. 6a). Lung 
immunofluorescence analysis of Cx3cr1-CreERT2 / Rosa26-loxp-STOP-loxp-TdTomato 
mice at day 14 after bleomycin injury indicated that the homodimeric form of Pdgfa, Pdgf-
aa, was highly and uniquely expressed in TdTomato+ cells adjacent to fibroblasts that were 
positive for expression of Pdgfra, the receptor for Pdgf-aa (Fig. 6b).
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To test whether cluster C2 cells supported fibroblast migration or proliferation through 
production of Pdgf-aa, we performed in vitro assays with 3T3 fibroblasts, an embryonic 
mouse fibroblast cell line. Conditioned media from SiglecF+CD11c+MHCIIhi macrophages 
(corresponding to cluster C2) sorted from wild-type mice 14 days after bleomycin injury and 
cultured for 2 days enhanced gap closure by 3T3 fibroblasts compared to conditioned media 
from SiglecF+CD11c+MHCIIlo macrophages (corresponding to cluster C1) isolated from the 
same mice (Fig. 6c). Antibody blockade of Pdgf-aa inhibited the enhanced gap closure seen 
in SiglecF+CD11c+MHCIIhi compared to SiglecF+CD11c+MHCIIlo conditioned media (Fig. 
6c), suggesting the fibroblast response was dependent on Pdgf-aa secreted by SiglecF
+CD11c+MHChi macrophages. In a second assay, when TdTomato+ cells sorted 14 days 
after bleomycin injury in tamoxifen-induced Cx3cr1-CreERT2 / Rosa26-loxp-STOP-loxp-
TdTomato mice were co-cultured with 3T3 fibroblasts, Pdgf-aa blocking antibody decreased 
the proliferation of fibroblasts as measured by EDU uptake (Figure 6d).
Analysis of the lung scRNA-seq dataset including cells from both bleomycin-treated and 
steady-state lung pooled together and annotated by SingleR showed three clusters of 
fibroblasts, cluster A, B, and C (Fig. 6e). Pdgfra was not detected in the lung scRNA-seq 
dataset, which may reflect the limitation of the depth of sequencing with the single-cell 
method; however, a significant expansion of Pdgfra+ fibroblasts after bleomycin treatment 
has been reported in a study analyzing the fibroblast compartment in this model of fibrosis 
35
. Next, we used gene set analysis36 to quantify cell cycle genes in the lungs of bleomycin-
treated mice compared to steady state 14 days after bleomycin treatment. Cluster A showed 
the highest expression of cell cycle genes and was predominantly composed of cells from 
bleomycin-treated mice (Figure 6e).
To investigate the role of CX3CR1+ cells in the proliferation of fibroblasts in vivo, Cx3cr1-
CreERT2 / Rosa26-loxp-STOP-loxp-Diphteria Toxin A mice were treated with tamoxifen 
between day 8 and day 21 after bleomycin injury to induce diphtheria toxin A-dependent 
deletion of CX3CR1+ cells during the fibrotic phase of bleomycin lung injury. At 21 days 
after bleomycin injury, bleomycin-injured, tamoxifen-induced Cx3cr1-CreERT2 / Rosa26-
loxp-STOP-loxp-Diphteria Toxin A mice had significantly fewer macrophages quantified by 
immunofluorescent labeling of either Mertk+ or SiglecF+ cells in the lung (Supplementary 
Fig. 7), significantly decreased numbers of cells expressing the fibroblast markers Pdgfra+ 
and Pdgfrb+ (Fig. 7a), and significantly decreased lung collagen as measured by 
hydroxyproline assay compared to bleomycin-injured wild-type mice (Fig. 7b). This result 
indicates that CX3CR1+ macrophages were required for the expansion of the fibroblast 
compartment and the deposition of fibrotic scar.
In human patients, one pathologic feature of idiopathic pulmonary fibrosis is the presence of 
normal tissue adjacent to regions of fibrotic foci, which are commonly found in the 
subpleural region of the lung37. In three lung explants displaying such regional 
heterogeneity, we found that PDGF-AA+ macrophages were associated with the fibrotic 
rather than non-fibrotic regions (Fig. 7c). Together, these results suggest the dependence of 
fibroblast proliferation, which is a key step in fibrogenesis38, on trophism exerted by PDGF-
AA+ macrophages recruited to sites of injury.
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Discussion
We show here that during fibrogenesis CX3CR1+SiglecF+ macrophages localize to sites of 
Pdgfra+ and Pdgfrb+ fibroblast accumulation at sites of bleomycin-induced injury in the 
lung. Deletion of these macrophages during the fibrotic period (days 8–21) eliminated 
Pdgfra+ or Pdgfrb+ fibroblasts and total lung collagen. Mechanistic studies indicated that 
fibroblast migration and proliferation were dependent on secretion of Pdgf-aa by SiglecF
+CD11c+MHCIIhi and CX3CR1+ cells, respectively, suggesting that paracrine interactions 
between these macrophages and fibroblasts sustain fibroblast proliferation and tissue 
fibrosis.
Hierarchical clustering of correlation scores for macrophages with bulk datasets from 
ImmGen enabled the deconvolution of macrophage heterogeneity and identified three 
clusters of lung macrophages: alveolar macrophages (cluster C1), interstitial macrophages 
(cluster C3) and an intermediate cluster C2 bearing likeness to both alveolar and interstitial 
macrophages by gene expression. This analysis motivated the hypothesis that C2 is a 
transitional state arising after injury, which was supported by labeling and expression studies 
revealing kinetic transition toward increasing expression of the alveolar macrophage (C1) 
marker SiglecF by cells expressing the C2 and C3 marker Cx3cr1.
In cell culture systems, we found that antibody blockade of Pdgf-aa decreased the enhanced 
3T3 fibroblast gap closure induced by conditioned media from MHCIIhi alveolar 
macrophages (corresponding to cluster C2) as well as the proliferation of 3T3 fibroblasts in 
co-culture with CX3CR1+ macrophages from bleomycin injured mice. Of note, one of the 
few FDA-approved therapies for lung fibrosis, the small molecule receptor tyrosine kinase 
inhibitor nintedanib, blocks PDGF receptor signaling39, and Pdgfra expressed by fibroblasts 
drives fibrosis in multiple organs in mice40–45, including lung fibrosis induced by bleomycin 
treatment46. These observations indicate that the Pdgf pathway is crucial to disease 
pathogenesis. Our results implicate the CX3CR1+SiglecF+ macrophage as the source of 
Pdgf-aa in the fibrotic niche.
A recent study reported an increase in the number of Ceacam1+Msr1+Ly6C−F4/80−Mac1+ 
monocytes, named segregated-nucleus containing atypical monocytes or ‘SatM’, in the 
bronchoalveolar lavage at day 13 after bleomycin treatment in mice11. SatM cells were 
found to be pro-fibrotic when transferred to the lung intravenously. However, macrophages 
were not tested, whereas our study characterizes these macrophage populations specifically. 
Furthermore, cells in that study were isolated by bronchoalveolar lavage, which does not 
efficiently recover cells from fibrotic regions. In the current study, we used dissociated 
whole lung for single cell analysis, which enabled an unbiased view of all cellular subtypes 
in the lung.
Our observation that ablation of macrophages expressing Cx3cr1 decreased fibroblasts and 
lung collagen content after bleomycin treatment has relevance for human disease. A similar 
macrophage gene expression profile was identified in an alternate mouse model of lung 
fibrosis mediated by telomere dysfunction, and analysis of human lung samples indicated 
increased expression of CX3CR1 and MHCII genes in patients with fibrosis as well as the 
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expression of the C2 and C3 markers MAFB and PDGF-AA in regions of active fibrosis. 
These findings underscore the potential therapeutic significance of our functional studies in 
mice.
A limitation of using Cx3cr1-CreERT2 is that Cx3cr1 is expressed in both clusters C2 and 
C3, limiting the specificity of our studies. Our analysis suggests an evolution of cluster C3 
towards cluster C1, with C2 representing a transitional state. Future studies should 
characterize the kinetics of this transition in greater depth and determine whether specific 
ablation of either cluster across time may be possible. Second, our annotation of cell states 
using SingleR relies on the particularities of the reference datasets. The ImmGen database is 
a large compendium of cell types from multiple organs, which greatly facilitated our 
clustering analysis by differential annotation. Nonetheless, we anticipate that the power of 
SingleR to identify new cell types or cell states will continue to increase as single cell and 
bulk RNA-seq datasets are amassed from a range of contexts.
In summary, this study identified a profibrotic macrophage subpopulation that localizes to 
sites of fibrotic scar with activating effects on the mesenchyme. Furthermore, the 
identification of markers specific for the profibrotic macrophages, including CX3CR1 and 
PDGF-AA, could be useful for therapeutic targeting in clinical fibrosis. Our results also 
demonstrate the value of using reference-based annotation of single cell datasets in order to 
map the heterogeneity of canonical cell types, such as macrophages, and to enhance the 
differentiation of transcriptomically unique subclusters within the data. Coupled with 
lineage tracing and functional studies, this approach should serve as a broadly applicable 
platform for study of specific cellular compartments in health and disease.
Online Methods
Mice
Ai14 (Rosa26-LSL-tdTomato), DTA (Gt(ROSA)26Sortm1(DTA)Lky), CX3CR1-CreERT2 
(Cx3cr1tm2.1(cre/ERT2)Jung), and TRF1fl/fl, all on C57BL/6 background, wild type C57BL/6, 
and wild type 129S1 mice were obtained from the Jackson Laboratory. SPC-CreERT2rtTA 
mice, on C57BL/6 background, were obtained from Hal Chapman. Strain-appropriate 
controls were used in all experiments, and genotyping of the mice was performed by PCR. 
Cx3cr1-CreERT2 mice were administered 2 mg tamoxifen (Sigma) via IP injection every 
other day for Cre induction. Mice were maintained in specific-pathogen-free conditions in 
the Animal Barrier Facility of the University of California, San Francisco. All animal 
experiments were in accordance with protocols approved by the UCSF Institutional Animal 
Care and Use Committee.
Microfabrication of Devices
The PDMS Drop-seq droplet microfluidic device is fabricated with standard soft lithography 
techniques. Photoresist masters are created by spinning a layer of photoresist SU-8 
(Microchem) onto a 3-inch silicon wafer (University Wafer), then baking at 95 °C for 20 
minutes. Then, the photoresist is subjected to a 3-minute ultraviolet light exposure over 
Drop-seq (19) photolithography masks (CAD/Art Services) printed at 12,000 DPI. After 
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ultraviolet exposure, the wafers are baked at 95 °C for 10 min, developed in fresh propylene 
glycol monomethyl ether acetate (Sigma Aldrich), rinsed with fresh propylene glycol 
monomethyl ether acetate, and baked at 95 °C for 1 minute to remove solvent. The 
microfluidic devices are fabricated by curing poly(dimethylsiloxane) (10:1 polymer-to-
crosslinker ratio) over the photoresist master47. The devices are cured in a 65 °C oven for 2 
hours and extracted with a scalpel, and inlet ports are added using a 0.75 mm biopsy core 
(World Precision Instruments). The device is bonded to a glass slide using O2 plasma 
treatment, and channels are treated with Aquapel (PPG Industries) to render them 
hydrophobic. Finally, the devices are baked at 65 °C for 20 min to dry the Aquapel before 
they are ready for use.
Drop-seq and data analysis
For scRNA-seq analysis of lung fibrosis, bleomycin (3 U/kg; Hospira) or water was instilled 
intratracheally to anesthetized male 129S1 mice, age 10–12 weeks. After 14 days, mice were 
sacrificed, and lungs were perfused with PBS and dissociated to a single-cell suspension in 
RPMI containing 0.13 U of liberase TM (Roche) and dissociated using gentleMACS 
(Miltenyi Biotec). Cells were passed through a 70 μm and 40 μm strainers followed by 
FACS sorting of DAPI- (live) cells. The single cell RNA-seq experiment is performed based 
on the Drop-seq protocol36. Briefly, the barcoded Drop-seq beads (ChemGenes corporation, 
MACOSKO-2011–10) and single cell suspensions from dissociated mouse lung are re-
suspended to 100 beads/μl in PBS-BSA buffer and 120 cells/μl in Drop-seq lysis buffer (with 
additional 1 M NaCl added), respectively. Monodisperse droplets ∼1 nL in size were 
generated using the fabricated Drop-seq device. We used HFE7500 with 2% w/v ionic 
krytox as oil phase. The collected droplets were broken with perfluorooctanol (Sigma) in 30 
ml of 6× SSC buffer. The beads were then washed and re-suspended in a reverse 
transcriptase mix for reverse transcription and the template switch reaction. Exonuclease I is 
used to remove unextended primers following the RT reaction. The beads were then washed, 
counted, aliquoted into PCR tubes as 6000 beads per PCR reaction, and PCR-amplified for 
17 cycles: 95°C for 3 min; then 4 cycles of: 98°C for 20 sec, 65°C for 45 sec, 72°C for 3 
min, and 13 cycles of: 98°C for 20 sec, 67°C for 20 sec, 72°C for 3 min; finally, 72°C for 5 
min. The PCR reactions from one Drop-seq run were pooled and purified with AMPure XP 
beads; the amplified cDNA was quantified with Qubit dsDNA high sensitivity assay and 
checked on a BioAnalyzer High Sensitivity Chip (Agilent). The cDNA was fragmented and 
amplified for sequencing with the Nextera XT DNA sample prep kit (Illumina) using a 
primer that enabled the specific amplification of only the 3′ ends and Illumina index 
primers N70X. The libraries were purified with Ampure beads, quantified with Quabit 
dsDNA high sensitivity assay, checked on a BioAnalyzer High Sensitivity Chip, and then 
sequenced on Illumina Miseq or Hiseq2000. Paired-end sequence reads were processed 
mostly as previously described36. Briefly, cell barcode and UMI are extracted from Read 1. 
Read 2 was aligned to the mouse mm10 genome (UCSC) using Bowtie48. Reads mapping to 
exonic regions of genes of mouse mm10 genome were recorded. The number of transcripts 
for a given gene within a cell barcode was determined by counting unique UMIs and were 
compiled into a digital gene expression (DGE) matrix.
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For initial clustering, we used Seurat v2.236 to cluster pooled data counts from 10 batches 
(42,000 cells, estimated based on the number of Drop-seq beads recovered, the 
concentration of cells, and droplet size). Cells with less than 500 non-zero genes were 
filtered out; genes expressed in only 1 cell were omitted. Altogether, the filtered data 
contained 8,366 cells and 13,861 genes (Supplementary Table 1). Expression data was log-
normalized, and data were scaled to regress out differences in number of detected molecules. 
Variable genes were identified using the FindVariableGenes function with a x.low.cutoff = 
0.0125, x.high.cutoff = 3 and y.cutoff = 0.5. t-SNE plot was computed using the top 10 
principal components.
Cell Type Annotation of Single Cells (SingleR)
The SingleR pipeline is based on correlating gene expression of pure cell types with single-
cell gene expression. SingleR can be used with any reference dataset. For mouse samples, 
we used the Immunological Genome Project (ImmGen) database, a collection of 830 
microarray samples, which we classified to 20 main cell types and further annotated to 253 
subtypes12; a dataset of 358 mouse RNA-seq samples annotated to 28 cell types collected, 
processed and shared, courtesy of Bérénice Benayoun, can also be used. For human samples 
we used the datasets from Blueprint Epigenomics, 144 RNA-seq pure immune samples 
annotated to 28 cell types14, and Encode, 115 RNA-seq pure stroma and immune samples 
annotated to 17 cell types13. More reference datasets for mouse and human are available 
with the SingleR R package. For specific applications, smaller datasets can be applicable (as 
demonstrated in figure 2c).
The annotation in SingleR is performed for each single cell independently. First, a Spearman 
coefficient is calculated for single-cell expression with each of the samples in the reference 
dataset. The correlation analysis is performed only on variable genes in the reference 
dataset. Next, multiple correlation coefficients per cell type according to the named 
annotations of the reference dataset are aggregated to provide a single value per cell type per 
single cell. SingleR uses the 80th percentile of correlation values, to prevent misclassification 
due to heterogeneity in the reference samples. Finally, in the fine-tuning step, SingleR reruns 
the correlation analysis, but only for the top cell types from the previous step. The analysis is 
performed only on variable genes between these cell types (see below). The lowest value cell 
type is removed (or values more than 0.05 below the top value), and then this step is 
repeated until only two cell types remain. The cell type corresponding to the top value after 
the last run is assigned to the single cell. Using only variable genes increases the ability to 
distinguish closely related cell types. Variable genes are defined as the top N genes that have 
a higher median expression in a cell type compared to each other cell type; we use a varying 
N, depending on the number of cell types used in the analysis. In the first round, N is 20 
genes per cell type if there are 253 cell types (as in our ImmGen reference) or 71 genes per 
cell type if there are 28 cell types (as in our Blueprint+Encode reference). In the last fine-
tuning step, N=333. More detail can be found in Supplementary Information 1 and at the 
SingleR Github repository https://github.com/dviraran/SingleR.
Clustering in Figure 3a was performed using Ward’s hierarchical agglomerative clustering 
method based on the SingleR scores across all cell types. Deconvolution analysis in Figure 
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2d was performed using the DeconRNA-seq package28 using the average expression of AM 
samples and average expression of IM3 samples from GSE9413527. Differential expression 
analysis (Figure 3b) was performed using the Seurat package v2.2 with default parameters.
Bulk RNA-seq
For bulk RNA-seq analysis of lung fibrosis, bleomycin (3 U/kg; Hospira) or water was 
instilled intratracheally to anesthetized male 129S1 mice, age 10–12 weeks. Cells gated on 
SiglecF+CD11c+ and sorted on MHCIIhi or MHCIIlo (Supplementary Fig. 6a) were collected 
at 2 weeks and 4 weeks after injury, or at baseline for the MHCIIlo compartment. RNA was 
collected (RNeasy Micro, Qiagen) from these samples, and total RNA quality was assessed 
by spectrophotometer (NanoDrop, Thermo Fisher Scientific Inc., Waltham, MA) and the 
Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA). Intact mRNA was isolated 
using the Dynabead mRNA Purification Kit for total RNA, according to manufacturer’s 
protocol (Thermo Fisher Scientific, Waltham, MA). Amplified cDNA was prepared using 
the NuGen Ovation RNA-Seq system V2 kit, according to the manufacturer’s protocol 
(NuGen Technologies, Inc., San Carlos, CA), and sequencing libraries were generated using 
the Nextera XT library preparation kit with multiplexing primers according to 
manufacturer’s protocol (Illumina, San Diego, CA). Library fragment size distributions were 
assessed using the Bioanalyzer 2100 and the DNA high-sensitivity chip (Agilent 
Technologies, Santa Clara, CA). Library sequence quality was assessed by sequencing 
single-end 50 base pair reads using the Illumina MiSeq platform, and libraries were pooled 
for high-throughput sequencing on the Illumina HiSeq 4000 by using equal numbers of 
uniquely mapped protein coding reads. RNA sequencing was performed on HiSeq 4000 
machines (Illumina, San Diego, CA), followed by de-multiplexing of raw sequencing 
results, trimming of adapter sequences, and alignment to the reference genome using STAR 
software49. DESeq2 was used to normalize by size factor (reads per sample) as well as by 
library complexity, and we then applied Wald test to determine significance of differential 
expression.
Public gene expression data
Immunological Genome Project (ImmGen) raw expression data of phase 1 and 2 were 
downloaded as CEL files from GEO (GSE15907 and GSE37448), processed and normalized 
using the Robust Multi-array Average (RMA) procedure on probe-level data using Matlab 
functions. The analysis was performed using custom CDF file obtained from Brainarray50. 
Blueprint and Encode data were processed as we described previously51. Raw counts from 
the lung reference dataset were obtained from Gibbings et al.27 (GSE94135) and Altboum et 
al.26 (GSE49932). Counts were normalized and converted to TPM using R functions. Gene 
expression profile of GM-CSF derived bone marrow dendritic cell subsets (available at 
GSE6236118) was analyzed using the GEO2R tool for differentially expressed genes. Top 50 
upregulated by fold-change of GM-DCs genes and top 50 GM-Macs were used in Figure 1b. 
Single-cell RNA-seq counts from Hashimshony et al.15 used in Figure 1b were downloaded 
from the ARCHS project52. 10X PBMC single-cell counts were downloaded directly from 
the 10X website (https://support.10xgenomics.com/single-cell-gene-expression/datasets ).
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Analysis of published human lung microarray datasets
Yang et al.32 performed gene expression profiling for 167 lung tissues from idiopathic 
interstitial pneumonia subjects and 50 healthy controls. We downloaded raw CEL files GEO 
(Accession GSE32537) and processed them using custom CDFs from BrainArray. 
Normalization was performed using the Robust Multi-array Average (RMA) procedure on 
Affymetrix microarray data. Single-sample gene set enrichment analysis (ssGSEA31) was 
performed using human orthologues of C1 genes (Supplementary Table 3) and 15 human 
MHCII genes (HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, 
HLA-DPB2, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DQB2, HLA-DRA, HLA-
DRB1, HLA-DRB5, HLA-DRB6).
Microarray profiling in telomere dysfunction model of lung fibrosis
SPC-creERT2 / TRF1flox/flox mice and TRF1flox/flox litter-mate controls were subjected to 
tamoxifen administration beginning at 8 weeks age, as previously described30. Lungs 
perfused free of blood were harvested at 3 months and 9 months. Total RNA including small 
RNAs was extracted using miRNAeasy mini kit (Qiagen, Hilden, Germany). Total RNA was 
measured using the NanoDrop photospectrometer (NanoDrop, Wilmington, DE, USA). 
Agilent mouse microarray kit 8×60K v2 (G4852B) (Agilent technologies Inc., Santa Clara, 
CA, USA) was used. Gene expression profiling was performed by Onearray (Phalanx bio 
INC., San Diego, CA). All the samples passed the quality control parameters established by 
Agilent. Cy3-labeled aRNA was used for hybridization.
Single cell dissociation for FACS
Lungs were perfused with PBS and dissociated to a single cell solution in 10mM HEPES 
RPMI containing 0.2% collagenase (Wako Pure Chemical Industries), 0.1 mg/mL Dispase II 
(Roche), and 2000 U/mL DNase I (Merck). Cells were passed through a 70 μm strainer and 
stained at 4 °C for 30 minutes with following antibodies (1:100): SiglecF-APC (catalog 
number 50–1702-82, clone 1RNM44N, eBioscience), MHCII-APC-Cy7 (catalog number 
47–5321-82, clone M5/114.15.2, eBioscience), and CD11c-PE (catalog number 557401, 
clone HL3, BD Biosciences). Cells were sorted either with BD FACSAria2 or SONY SH800 
FACS. Data for analytical flow was analyzed using FlowJo software.
Immunostaining and Microscopy
Mouse lungs in the bleomycin model were perfused with PBS, inflated with 50% OCT, 10% 
sucrose in PBS and fixed overnight at 4 C in 4% PFA prior to freezing in OCT. Lungs from 
the telomere dysfunction model were perfused with PBS and frozen in OCT. For human 
samples OCT embedded tissues were cut to 15 μm sections, and sections were fixed with 4% 
PFA for 15 minutes at RT. OCT embedded tissues were cut to 15um sections, blocked with 
3% donkey serum, 1% BSA, 0.3% TritonX and then stained with following antibodies 
(1:100 dilution): SiglecF (catalog number AF1706, R&D Systems), Mertk (catalog number 
AF591, R&D Systems), Pdgfrb (catalog number 14–1402-82, clone APB5, eBioscience), 
CD68 (catalog number ab955, clone KP1, Abcam), MafB (catalog number HPA005653, 
Sigma), PDGF-AA antibody (catalog number 07–1436, Millipore), and Pdgfra antibody 
(catalog number AF1062, R&D Systems). Secondary antibodies conjugated to Alexa 
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fluorophores (Invitrogen and Abcam) were used at 1:200 dilution. Stained sections and 2-
photon images of second harmonic signal were visualized at Zeiss LSM 780 NLO 
microscope. Image processing was done using ImageJ. For quantitation of Figure 5b, 
regions of fibroblast accumulation were delimited by Pdgf receptor staining. For quantitation 
of Figure 7a, mean fluorescent intensity of Pdgfra and Pdgfrb immunostaining was 
measured from cellular areas as defined by morphological tissue features. For quantitation of 
Figure 7c, % second harmonic signal was determined for each image, and the median across 
images (within patient) was defined as the threshold for categorization as fibrotic versus 
nonfibrotic. For hematoxylin and eosin (H&E) images, staining of frozen sections was 
performed using standard protocols, and images of whole sections were acquired on a 
VERSA automated slide scanner (Leica Biosystems) equipped with an Andor Zyla 5.5 
sCMOS camera (Andor Technologies) acquired under NIH S10 grant OD021717; individual 
images were generated with the ImageScope software (Aperio Technologies, Vista, CA).
Fibroblast Migration Assay
3T3 mouse fibroblasts were seeded at 100% confluency into a 96-well plate with a central 
cell-free detection zone in the center of each well (Platypus technologies). 100 μl of 
conditioned media of macrophage cultures (48h culture in RPMI containing 10% FBS) were 
added per well. Pdgf-aa antibody (catalog number 07–1436, Millipore) was added at 
concentration 0.05 μg/ml. Cells were imaged via bright field microscopy at time points 0h 
and 24h. Image processing and migration quantification was done using ImageJ.
Fibroblast Proliferation Assay
Fibroblast proliferation by flow cytometric EDU assay was performed according to the 
manufacturer’s protocol (Click-iT Flow Cytometry, Invitrogen). 3T3 mouse fibroblasts, and 
TdTomato+ macrophages sorted from Cx3cr1-CreERT2 / Rosa26-loxp-STOP-loxp-
Tdtomato mice 2 weeks after bleomycin injury, were seeded at a ratio of 1:3 in serum-free 
conditions in the presence of Pdgf-aa blocking antibody (catalog number 07–1436, 
Millipore) or IgG control (catalog number ab199376, lot GR3195151–2, Abcam). EDU was 
added at 48 hours, and cells were suspended two hours later for EDU detection in the 
TdTomato- (fibroblast) fraction on a SONY SH800 flow cytometer.
Measurement of hydroxyproline
Lung hydroxyproline content was measured as previously described6 three weeks after 
intratracheal instillation of bleomycin to sex-matched, male and female, 8–12-week-old 
C57BL/6J mice. Briefly, mouse lungs were incubated in 12 N HCl at 110°C for 18 h. 
Aliquots of the samples reconstituted in distilled water were added to 1.4% chloramine-T in 
10% isopropanol and 0.5 M sodium acetate. Erlich’s solution was added, and the samples 
were incubated at 60°C for 10 min. Absorbance at 562 nm was measured and adjusted 
according to standard curves.
Human Lung Tissues
Written informed consent was obtained from all subjects, and the study was approved by the 
UCSF institutional review board. Pulmonary fibrosis lung tissues were obtained at the time 
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of lung transplantation from patients with a pathologic diagnosis of usual interstitial 
pneumonia and a consensus clinical diagnosis of idiopathic pulmonary fibrosis (IPF) 
according to available guidelines53. Age-similar, non-diseased, normal lung tissues were 
procured from lungs not used by the Northern California Transplant Donor Network54. Our 
studies indicate that these lungs are physiologically and pathologically normal. Lung 
fragments were inflated with 30% OCT suspended in PBS, embedded in OCT compound, 
mand frozen immediately after isolation in dry ice before storing at −80 °C until use.
Statistical analysis
All significance tests in this paper, unless otherwise stated, were assessed using the two-
sided Wilcoxon rank-sum test.
Reporting Summary
Further information on research design is available in the Nature Reporting Summary linked 
to this article.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Reference-based annotation of scRNA-seq.
a, Schematic of SingleR, a protocol for cell-type annotation by reference to transcriptomes 
of pure cell types. b, tSNE plot of a published scRNA-seq dataset of fibroblast and bone 
marrow-derived dendritic cells15 (top left). Heatmap of SingleR scores for top correlated cell 
types (top right). SingleR annotation of cell identity indicated on t-SNE plot (bottom left). 
Expression in single cells of genes derived by differential expression analysis of published 
microarray data from bone marrow-derived, GM-CSF-cultured macrophages (GM-Macs) 
and DCs (GM-DCs)18 (bottom right). c, t-SNE plots of a published scRNA-seq dataset of 
PBMC20 analyzed by Seurat without (top) and with (middle) SingleR annotations indicated 
for individual cells. Cell type markers expressed by SingleR annotation (bottom). TCM = 
central memory T cell; TEM=effector memory T cell.
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Figure 2. Reference datasets reveal heterogeneity of macrophage subtypes in lung fibrosis.
a-c, t-SNE plots of single-cell suspensions from mouse whole lung sequenced by Drop-seq 
color-coded by condition (a); annotated by SingleR using the ImmGen database as reference 
(b); and annotated by SingleR with lung-specific myeloid datasets26,27 (c). Data shown pool 
replicates (n=3 biologically independent mice for bleomycin-injured and n=6 biologically 
independent mice for healthy control). d, Quantification of similarity in gene expression of 
individual cells to bulk RNA-seq profiles of alveolar macrophages (AM) and CD11c+ 
interstitial macrophages (IM)27.
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Figure 3. Hierarchical clustering by reference annotation reveals a transitional macrophage in 
fibrosis.
a, Heatmap of SingleR annotation scores derived by reference to the ImmGen database with 
clusters superimposed on the t-SNE plot. MF = macrophages. b, Heatmap of genes 
differentially expressed between C1 and C3 with examples superimposed on the t-SNE plot. 
Cells are ordered by the number of non-zero C3 genes. c, Percentage of cells in each cluster 
that express genes in b (differentially expressed between C1 and C3). Asterisk indicates that 
45% of C2 cells express at least 33% of C1 genes and at least 33% of C3 genes. d, Heatmap 
of the expression of C3 genes in bulk RNA-seq of alveolar macrophages (SiglecF+CD11c+) 
sorted on MHCIIlo at baseline and both MHCIIlo and MHCIIhi at two time points after 
bleomycin lung injury (n=2 mice biologically independent mice for baseline, n=3 
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biologically independent mice at 2 weeks, and n=3 biologically independent mice at 4 
weeks).
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Figure 4. Markers of macrophages identified by scRNA-seq are found in multiple fibrosis 
models.
a, Heatmap of C3 genes from bleomycin-induced fibrosis measured by microarray in an 
epithelial telomere dysfunction model of progressive lung fibrosis (n=3 biologically 
independent mice in each condition, center value is mean). b, Gene set enrichment analysis 
scores of human orthologues of cluster C1 genes and of MHCII genes in bulk RNA-seq 
samples from patient lung biopsy specimens32. Points indicate individual microarray 
samples from n=167 and n=50 patients and controls, respectively. c, Immunofluorescence of 
human fibrotic and healthy control lung (representative images are shown; quantitation is for 
n=3 independent fibrotic patient lung and n=3 independent healthy lung samples, 10 images 
per sample). Scale bar, 50 μm. SH=second harmonic imaging of collagen. Box plot center 
line is median, box limits are upper and lower quartiles, and whiskers denote the largest and 
smallest values no more than 1.5 times the interquartile range from the limits. Wilcoxon test 
2-tailed p-values are presented. * p<0.01, ** p<0.0001.
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Figure 5. Transitional macrophages expressing CX3CR1, MHCII, and SiglecF localize to sites of 
fibroblast accumulation after lung injury.
a, Flow cytometry of TdTomato+ lung cells in Cx3cr1-CreERT2 / Rosa26-loxp-STOP-loxp-
TdTomato mice with tamoxifen administration before and after injury followed by flow 
cytometry, with representative pseudocolor plots and values plotted for TdTomato+ cells at 
three different time points (n=3 biologically independent mice per group, mean is marked). 
b, Lung immunofluorescence at 14 days after injury in Cx3cr1-CreERT2 / Rosa26-loxp-
STOP-loxp-TdTomato mice treated as in a (representative images are shown; quantitation is 
for n=3 biologically independent mice, 5 images per mouse). Scale bar, 50 μm. c, 
Expression of CX3CR1 in bulk RNA-seq samples from patient lung biopsy specimens32. 
Box plot center lines are median, box limits are upper and lower quartiles, and whiskers 
denote the largest and smallest values no more than 1.5 times the interquartile range from 
the limits. Wilcoxon test 2-sided p-values are presented. * p <0.001; ** p < 0.0001.
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Figure 6. Pdgf-aa is a macrophage-derived trophic factor for fibroblasts.
a, Pdgfa expression in lung scRNA-seq macrophage clusters and by bulk RNA-seq of 
SiglecF+CD11c+ lung macrophages after bleomycin injury. Mean is marked. Wald test 2-
sided p-value is presented (for the lung scRNA-seq data, n=3 biologically independent mice 
for bleomycin-injured and n=6 biologically independent mice for healthy control; for the 
bulk RNA-seq data, n=2 biologically independent mice for baseline, n=3 biologically 
independent mice for all other conditions). b, Lung immunofluorescence at baseline 
(bottom) and 14 days after injury (top) in tamoxifen-induced Cx3cr1-CreERT2 / 
Rosa26loxpSTOPloxp-TdTomato mice (representative images are shown; quantitation is for 
the 14-day time point in n=3 biologically independent mice, 5 images per mouse). Scale bar, 
50 μm. c, 3T3 fibroblast gap closure in response to conditioned media (CM) from lung 
macrophages sorted by MHCII expression, with and without Pdgf-aa blocking antibody (Ab; 
n=8 biologically independent mice total, each point a separate assay). d, EDU quantitation 
in 3T3 fibroblasts co-cultured with TdTomato+ cells sorted from tamoxifen-induced Cx3cr1-
CreERT2 / Rosa26-loxp-STOP-loxp-TdTomato mice 14 days after injury. Mean is marked 
(n=3 biologically independent co-cultures). e, t-SNE of SingleR-annotated fibroblasts from 
the lung scRNA-seq dataset showing intensity of cell cycle signature (n=3 biologically 
independent mice for bleomycin, n=6 biologically independent mice for control). Box plot 
Aran et al. Page 25
Nat Immunol. Author manuscript; available in PMC 2019 July 14.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
center lines are median, box limits are upper and lower quartiles, and whiskers denote the 
largest and smallest values no more than 1.5 times the interquartile range from the limits. 
Wilcoxon test 2-sided p-values are presented. * p < 0.01; ** p < 0.0001.
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Figure 7. Cx3cr1-derived macrophages drive fibroblast accumulation and fibrosis after lung 
injury.
a, Lung immunofluorescence of fibroblast and macrophage markers 21 days after bleomycin 
injury in Cx3cr1-CreERT2 / Rosa26-loxp-STOP-loxp-Diphtheria Toxin A and wild-type 
mice (quantitation is for n=3 biologically independent mice per group, 5 images per mouse). 
b, Fibrosis measured by hydroxyproline assay for lung collagen content in mice treated as in 
a (blue points are Cx3cr1-CreERT2 / Rosa26loxpSTOPloxp-Diptheria Toxin A mice and red 
points are wild type; n=10, n=7, and n=7 biologically independent mice per group from left 
to right). Scale bar, 50 μm. c, Immunofluorescence of fibrotic (high SH) and non-fibrotic 
(low SH) regions from explanted human fibrotic lung, with quantification of individual 
images from 3 separate patients (8 high and 9 low regions in patient 1, 16 high and 16 low in 
patient 2, and 3 high and 6 low in patient 3). SH=second harmonic signal for collagen. Scale 
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bar, 50 μm. Box plot center lines are median, box limits are upper and lower quartiles, and 
whiskers denote the largest and smallest values no more than 1.5 times the interquartile 
range from the limits. Wilcoxon test 2-sided p-values are presented. * p < 0.05; ** p < 0.01; 
*** p < 0.001; **** p < 0.0001.
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